BIOIX Mutual Fund

BIOIX Mutual Fund

NAV$66.29
See how much of BIOIX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.05%
Dividend Yield (Current)
3.76%
Holdings
50
Inception Date
May 29, 2009
Fund Family
Baron Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+5.24%
1 Year+11.99%
3 Year+22.82%
5 Year+9.07%
10 Year+20.68%

Asset Allocation

Stocks: 100.00%
See how much of BIOIX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
NVDANvidia Corp.13.26%
SPCXSpace Exploration Technologies6.61%
AVGOBroadcom Inc6.28%
AMZNAmazon.Com Inc6.25%
ARKXSpace Exploration Tech Class A6.03%
Top 10 Concentration: 58.88%Report Date: Mar 31, 2026
Download all 50 holdings for BIOIX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.76%
Frequency
Annually
Latest Distribution
$3.60
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

BIOIX Mutual Fund Overview

BIOIX Mutual Fund (Baron Opportunity Fund Inst Shs) is managed by Baron Funds. BIOIX expense ratio is 1.05%, holding 50 positions across sectors including Information Technology, Consumer Discretionary, Communication Services. Inception date: 2009-05-29.

BIOIX performance shows a YTD return of 5.24%. The 1-year return is 11.99% and the 5-year return is 9.07%. BIOIX dividend yield stands at 3.76%, paid annually.

BIOIX top holdings include Nvidia Corp. (13.3%), Space Exploration Technologies (6.6%), Broadcom Inc (6.3%), Amazon.Com Inc (6.3%), Space Exploration Tech Class A (6.0%). Go to all BIOIX holdings, BIOIX sectors, or BIOIX dividends.

BIOIX can be compared against other funds. Use BIOIX overlap to find shared positions, or BIOIX vs another fund for a side-by-side view. BIOIX alternatives are available via the screener, along with tax-loss harvesting opportunities.